# Vulvoscopy Changes of the Vulva, Vestibule and Vagina With Daily Ospemifene in Women With Dyspareunia From VVA

> **NCT02784613** · PHASE4 · COMPLETED · sponsor: **Sue Goldstein** · enrollment: 10 (actual)

## Conditions studied

- Vulvovaginal Atrophy
- Dyspareunia

## Interventions

- **DRUG:** Ospemifene

## Key facts

- **NCT ID:** NCT02784613
- **Lead sponsor:** Sue Goldstein
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2017-02-07
- **Final completion:** 2017-04-17
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02784613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02784613, "Vulvoscopy Changes of the Vulva, Vestibule and Vagina With Daily Ospemifene in Women With Dyspareunia From VVA". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02784613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*